U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
MIRIKIZUMAB
Z7HVY03PHP
US Approved Rx (2023)
First approved in 2023
General
Names
7
Classification
2
Identifiers
9
Subunits
4
Related Substances
1
MIRIKIZUMAB
Z7HVY03PHP
US Approved Rx (2023)
First approved in 2023
General
Approval Year
2023
446
Names
7
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
MIRIKIZUMAB
Official Name
English
LY-3074828
Preferred Name
English
LY3074828
Code
English
MIRIKIZUMAB [USAN]
Common Name
English
mirikizumab [INN]
Common Name
English
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Classification
2
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of ulcerative colitis in pediatric patients
FDA ORPHAN DRUG
577817
Designated
ORPHAN DRUG
Designated
Treatment of pediatric Crohn's disease
FDA ORPHAN DRUG
584617
Showing 1 to 2 of 2 entries
Previous
1
Next
Identifiers
9
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
DAILYMED
Z7HVY03PHP
PRIMARY
FDA UNII
Z7HVY03PHP
PRIMARY
NCI_THESAURUS
C170182
PRIMARY
USAN
DE-114
PRIMARY
CAS
1884201-71-1
PRIMARY
Showing 1 to 5 of 9 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
Z7HVY03PHP
MIRIKIZUMAB
